HPR129 Is Cost-Effectiveness Analysis a Tool to Exercise Value-Based Pricing or Monopsony Power? Evidence from Canada and Other Countries
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1275
https://www.valueinhealthjournal.com/article/S1098-3015(23)01375-X/fulltext
Title :
HPR129 Is Cost-Effectiveness Analysis a Tool to Exercise Value-Based Pricing or Monopsony Power? Evidence from Canada and Other Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01375-X&doi=10.1016/j.jval.2023.03.1275
First page :
Section Title :
Open access? :
No
Section Order :
10707